GAIN THERAPEUTICS, INC Earnings Per Share (Basic)
GAIN THERAPEUTICS, INC (GANX) reported Earnings Per Share (Basic) of -$0.11 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- GAIN THERAPEUTICS, INC earnings per share, basic for the quarter ending 2026-06-30 was -$0.11.
- GAIN THERAPEUTICS, INC earnings per share, basic for the quarter ending 2026-03-31 was -$0.13.
- GAIN THERAPEUTICS, INC earnings per share, basic for the quarter ending 2025-12-31 was -$0.12.
- GAIN THERAPEUTICS, INC earnings per share, basic for the quarter ending 2025-09-30 was -$0.15.
- GAIN THERAPEUTICS, INC earnings per share, basic for fiscal 2025 was -$0.61.
- GAIN THERAPEUTICS, INC earnings per share, basic for fiscal 2024 was -$0.89.
- GAIN THERAPEUTICS, INC earnings per share, basic for fiscal 2023 was -$1.71.
- GAIN THERAPEUTICS, INC earnings per share, basic for fiscal 2022 was -$1.48.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.11 10-Q · filed 2026-08-11 | -$0.24 10-Q · filed 2026-08-11 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2026-03-31 | -$0.13 10-Q · filed 2026-05-11 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-12-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.61 10-K · filed 2026-03-26 |
| 2025-09-30 | -$0.15 10-Q · filed 2025-11-12 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.50 10-Q · filed 2025-11-12 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-06-30 | -$0.19 10-Q · filed 2026-08-11 | -$0.35 10-Q · filed 2026-08-11 | -$0.49 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-03-31 | -$0.16 10-Q · filed 2026-05-11 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.82 derived: net income ÷ weighted average shares · filed 2026-05-11 |
| 2024-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$0.89 10-K · filed 2026-03-26 |
| 2024-09-30 | -$0.17 10-Q · filed 2025-11-12 | -$0.55 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.78 10-Q · filed 2025-11-12 | -$1.09 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2024-06-30 | -$0.42 10-Q · filed 2025-08-12 | -$0.65 10-Q · filed 2025-08-12 | -$0.97 derived: net income ÷ weighted average shares · filed 2025-08-12 | -$1.33 derived: net income ÷ weighted average shares · filed 2025-08-12 |
| 2024-03-31 | -$0.22 10-Q · filed 2025-05-14 | -$0.53 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.88 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$1.46 derived: net income ÷ weighted average shares · filed 2025-05-14 |
| 2023-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$0.68 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$1.28 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$1.71 10-K · filed 2025-03-27 |
| 2023-09-30 | -$0.37 10-Q · filed 2024-11-14 | -$0.99 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$1.42 10-Q · filed 2024-11-14 | -$1.82 derived: net income ÷ weighted average shares · filed 2024-11-14 |
| 2023-06-30 | -$0.62 10-Q · filed 2024-08-08 | -$1.05 10-Q · filed 2024-08-08 | -$1.45 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$1.83 derived: net income ÷ weighted average shares · filed 2024-08-08 |
| 2023-03-31 | -$0.43 10-Q · filed 2024-05-14 | -$0.82 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$1.21 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$1.64 derived: net income ÷ weighted average shares · filed 2024-05-14 |
| 2022-12-31 | -$0.39 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$0.78 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$1.20 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$1.48 10-K · filed 2024-03-26 |
| 2022-09-30 | -$0.38 10-Q · filed 2023-11-14 | -$0.81 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$1.09 10-Q · filed 2023-11-14 | -$1.36 derived: net income ÷ weighted average shares · filed 2023-11-14 |
| 2022-06-30 | -$0.43 10-Q · filed 2023-08-10 | -$0.70 10-Q · filed 2023-08-10 | -$0.97 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$1.37 derived: net income ÷ weighted average shares · filed 2023-08-10 |
| 2022-03-31 | -$0.28 10-Q · filed 2023-05-12 | -$0.55 derived: net income ÷ weighted average shares · filed 2023-05-12 | -$0.94 derived: net income ÷ weighted average shares · filed 2023-05-12 | -$1.24 derived: net income ÷ weighted average shares · filed 2023-05-12 |
| 2021-12-31 | -$0.27 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$0.66 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$0.96 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$1.37 10-K · filed 2023-03-23 |
| 2021-09-30 | -$0.39 10-Q · filed 2022-11-10 | -$0.69 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.11 10-Q · filed 2022-11-10 | -$1.53 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2021-06-30 | -$0.30 10-Q · filed 2022-08-08 | -$0.71 10-Q · filed 2022-08-08 | -$1.13 derived: net income ÷ weighted average shares · filed 2022-08-08 | -$1.44 derived: net income ÷ weighted average shares · filed 2022-08-08 |
| 2021-03-31 | -$0.50 10-Q · filed 2022-05-16 | -$0.98 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$1.26 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$1.60 derived: net income ÷ weighted average shares · filed 2022-05-16 |
| 2020-12-31 | -$0.47 derived: net income ÷ weighted average shares · filed 2022-03-25 | -$0.73 derived: net income ÷ weighted average shares · filed 2022-03-25 | -$1.03 derived: net income ÷ weighted average shares · filed 2022-03-25 | -$1.33 10-K · filed 2022-03-25 |
| 2020-09-30 | -$0.25 10-Q · filed 2021-11-12 | -$0.52 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.80 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$0.27 10-Q · filed 2021-08-12 | -$0.57 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |